HEATHER CONN: Open Payments
NPI 1902248495 · PLEASANTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$987 in 44 payments from 13 companies in 2025. Trend: 2023 $678 · 2024 $1,111 · 2025 $987
Food & beverage: $987
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 9 | $322 |
| E.R. Squibb & Sons, L.L.C. | 9 | $165 |
| Merck Sharp & Dohme LLC | 7 | $113 |
| Actelion Pharmaceuticals US, Inc. | 3 | $91 |
| Amgen Inc. | 3 | $58 |
| Abbott Laboratories | 2 | $47 |
| CVRx, Inc. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| PFIZER INC. | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
Products named: AMVUTTRA, CAMZYOS, ONPATTRO, VERQUVO, UPTRAVI, REPATHA, AVEIR, Barostim Neo System.
Industry payments across TX — which companies pay providers there.
